Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy is a research paper published in Experimental Eye Research (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R43EY029210-01
Development of a first-in-class, potent and safe, small synthetic anti-angiogenic peptide for treatment of retinopathy of prematurity
Retina Research Foundation
Grant: P30 EY010572
Retina Research Foundation
Grant: P30 CA014520
Retina Research Foundation
Grant: R01 EY026078
Research to Prevent Blindness
Grant: P30 EY016665
NEI NIH HHS
Grant: R43 EY029210
National Institutes of Health
Grant: 5P30EY016665-15
Core Grant for Vision Research
National Institutes of Health
Grant: 5R01EY026078-04
Investigating oxygen metabolism in diabetic retinopathy
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 3P30EY010572-20S1
OPHTHALMOLOGY CORE FACILITY
Northwestern University
Small Business Innovation Research
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals